Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells

Neurochemical Research

Volumn 32, Issue 10, 2007, Pages 1673-1684

  Schonfeld, Eldi ^a   Yasharel, Ilanit ^a   Yavin, Ephraim ^a   Brand, Annette ^a,b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cell death; Docosahexaenoic acid; Iron; Lipid asymmetry; Oxidative stress; PC12 cells

Indexed keywords

DOCOSAHEXAENOIC ACID; DYE; IRON; LIPID PEROXIDE; METAL ION; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NERVE GROWTH FACTOR; NEUTRAL RED; POLYUNSATURATED FATTY ACID; TRANSFERRIN RECEPTOR;

ARTICLE; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL STRAIN; CELL VIABILITY; HUMAN; ION TRANSPORT; IRON TRANSPORT; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; ARACHIDONIC ACID; BLOTTING, WESTERN; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMATOGRAPHY, THIN LAYER; CULTURE MEDIA; DNA; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; IRON; LIPID METABOLISM; NERVE GROWTH FACTORS; OXIDATIVE STRESS; PC12 CELLS; PROSTAGLANDINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 34548742451     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9378-x     Document Type: Article

References (68)

1. Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 3:236-245
2. Yavin E, Brand A, Green P (2002) Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci 5:149-157
3. Blomgren K, Hagberg H (2006) Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med 40:388-397
4. Halliwell B, Chirico S (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57:S715-S725
5. Rice-Evans C, Burdon R (1993) Free radicals-lipid interactions and their pathological consequences. Prog Lipid Res 32:71-110
6. Sheu SS, Nauduri D, Anders MW (2006) Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim Biophys Acta 1762:256-265
7. Terman A, Brunk UT (2006) Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid Redox Signal 8:197-204
8. Lee JC, Son YO, Choi KC et al (2006) Hydrogen peroxide induces apoptosis of BJAB cells due to formation of hydroxyl radicals via intracellular iron-mediated Fenton chemistry in glucose oxidase-mediated oxidative stress. Mol Cells 22:21-29
9. Palmer C, Roberts L, Bero C (1994) Deferoxamine post-treatment reduces ischemia brain injury in neonatal rats. Stroke 25:1039-1045
10. Dai L, Winyard PG, Zhang Z et al (1996) Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin. Biochim Biophys Acta 1304:223-228
11. Double KL, Maywald M, Schmittel M et al (1998) In vitro studies of ferritin iron release and neurotoxicity. J Neurochem 70:2492-2499
12. Shadid M, Buonocore G, Groenendaal F et al (1998) Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett 248:5-8
13. Sorond FA, Ratan RR (2000) Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signal 2:421-436
14. Zheng H, Gal S, Weiner LM et al (2005) Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. J Neurochem 95(1):68-78
15. Berg D, Youdim MB (2006) Role of iron in neurodegenerative disorders. Top Magn Reson Imag 17(1):5-17
16. de los Monteros AE, Korsak RA, Tran T et al (2000) Dietary iron and the integrity of the developing rat brain: a study with the artificially-reared rat pup. Cell Mol Biol (Noisy-le-grand) 46:501-515
17. Maynard CJ, Cappai R, Volitakis I et al (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277:44670-44676
18. Zecca L, Youdim MB, Riederer P et al (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873
19. Bartzokis G, Tishler TA, Lu PH et al (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28(3):414-423
20. Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25:5-18
21. Zalska MM, Floyd RA (1985) Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res 10:397-410
22. Stohs SJ, Bagchi D (1995) Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18:321-336
23. Homan JA, Radel JD, Wallace DD et al (2000) Chemical changes in the photoreceptor outer segment due to iron induced oxidative stress: analysis by Fourier transform infrared (FT-IR) microspectroscopy. Cell Mol Biol 46:663-672
24. Honda K, Smith MA, Zhu X et al (2005) Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem 280:20978-20986
25. Katsuki H, Okuda S (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46:607-636
26. Fernandes G, Troyer DA, Jolly CA (1998) The effects of dietary lipids on gene expression and apoptosis. Proc Nutr Soc 57:543-550
27. Relton JK, Strijbos PJLM, Cooper AL et al (1993) Dietary n-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. Brain Res Bull 32:223-226
28. Billman GE, Hallaq H, Leaf A (1994) Prevention of ischemia-induced ventricular fibrillation by omega-3 fatty acids. Proc Natl Acad Sci USA 91:4427-4430
29. Yavin E, Brand A (2005) From intramolecular asymmetries to raft assemblies: a short guide for the puzzled in lipidomics. In: Mattson MP (eds) Membrane microdomain signaling. Humana Press, Totowa, New Jersey, pp1-14
30. Brand A, Gil S, Yavin E (2000) N-methyl bases of ethanolamine prevent apoptotic cell death induced by oxidative stress in cells of oligodendroglia origin. J Neurochem 74:1596-1604
31. 2-induced apoptotic cell death via ERK activation. J Neurochem 76:910-918
32. Brand A, Yavin E (2001) Early ethanolamine phospholipid translocation marks stress-induced apoptotic cell death in oligodendroglial cells. J Neurochem 78:1208-1218
33. Brand A, Yavin E (2005) Translocation of ethanolamine phosphoglyceride is required for initiation of apoptotic death in OLN-93 oligodendroglial cells. Neurochem Res 30(10):1257-1267
34. Ikemoto A, Kobayashi T, Emoto K et al (1999) Effects of docosahexaenoic and arachidonic acids on the synthesis and distribution of amino phospholipids during neuronal differentiation of PC12 cells. Arch Biochem Biophys 364:67-74
35. Martin RE, Wickham JQ, Om AS et al (2000) Uptake and incorporation of docosahexaenoic acid (DHA) into neuronal cell body and neurite/nerve growth cone lipids: evidence of compartmental DHA metabolism in nerve growth factor-differentiated PC12 cells. Neurochem Res 25(5):715-723
36. Marszalek JR, Kitidis C, Dararutana A et al (2004) Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J Biol Chem 279(23):23882-23891
37. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428
38. Hinshaw DB, Miller MT, Omann GM et al (1993) A cellular model of oxidant-mediated neuronal injury. Brain Res 615(1):13-26
39. Richter-Landsberg C, Besser A (1994) Effects of organotins on rat brain astrocytes in culture. J Neurochem 63:2202-2209
40. Burton K (1968) Determination of DNA concentration with diphenylamine. Meth Enzymol 12B:163-166
41. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186:407-421
42. Sleight RG, Pagano RE (1983) Rapid appearance of newly synthesized phosphatidylethanolamine at the plasma membrane. J Biol Chem 258:9050-9058
43. 32P-labeled phospholipids by a simple and rapid two-directional thin-layer chromatography procedure and its application to cultured neuroblastoma cells. Anal Biochem 80:430-437
44. Riemer J, Hoepken HH, Czerwinska H et al (2004) Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal Biochem 331:370-375
45. Bradford MM (1986) A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:238-259
46. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1):1-9
47. Smeets EF, Comfurius P, Bevers EM et al (1994) Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochem Biophys Acta 1195:281-286
48. Rami A, Sims J, Botez G et al (2003) Spatial resolution of phospholipid scramblase 1 (PLSCR1), caspase-3 activation and DNA-fragmentation in the human hippocampus after cerebral ischemia. Neurochem Int 43:79-87
49. Mwanjewe J, Hui BK, Coughlin MD et al (2001) Treatment of PC12 cells with nerve growth factor increases iron uptake. Biochem J 357:881-886
50. Satoh T, Yamagata T, Ishikawa Y et al (1999) Regulation of reactive oxygen species by nerve growth factor but not Bcl-2 as a novel mechanism of protection of PC12 cells from superoxide anion-induced death. J Biochem (Tokyo) 125:952-959
51. Zhang L, Jope RS (1999) Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging 20:271-278
52. Schafer FQ, Qian SY, Buettner GR (2000) Iron and free radical oxidations in cell membranes. Cell Mol Biol (Noisy-le-grand) 46(3):657-662
53. Bradbury MWB (1997) Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 69:443-451
54. Wang J, Qian ZM, Jiang H et al (2005) Treatment with nerve growth factor decreases expression of divalent metal transporter 1 and transferrin receptor in PC12 cells. Neurochem Int 47:514-517
55. Roth JA, Horbinski C, Feng L et al (2000) Differential localization of divalent metal transporter 1 with and without iron response element in rat PC12 and sympathetic neuronal cells. J Neurosci 20(20):7595-7601
56. Gunshin H, Mackenzie B, Berger UV et al (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388(6641):482-488
57. Fadok VA, Bratton DL, Henson PM (2001) Phagocytes receptors for apoptotic cells: recognition, uptake and consequences. J Clin Invest 180:957-962
58. Reiss D, Beyer K, Engelmann B (1997) Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem J 323:807-814
59. Hahnel D, Beyer K, Engelmann B (1999) Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol. Free Radic Boil Med 27:1087-1094
60. Engelmann B (2004) Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 32(Pt 1):147-150
61. Kuczynski B, Reo NV (2006) Evidence that plasmalogen is protective against oxidative stress in the rat brain. Neurochem Res 31(5):639-656
62. Burdo JR, Connor JR (2003) Brain iron uptake and homeostatic mechanisms: an overview. BioMetals 16:63-75
63. Ong WY, Halliwell B (2004) Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann N Y Acad Sci 1012:51-64
64. Thomas M, Jankovic J (2004) Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol 17:437-442
65. Barcelo-Coblijn G, Hogyes E, Kitajka K et al (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci USA 100:11321-11326
66. Yehuda S, Rabinovitz S, Mostofsky DI (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 26S:S98-S102
67. Serrano F, Klann E (2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 3:431-443
68. Maher P (2005) The effects of stress and aging on glutathione metabolism. Ageing Res Rev 4:288-314